As of November 6, 2026, 3 holders' latest Schedule 13D or 13G filings report owning 5% or more of AngioDynamics, Inc. The largest reported stake is Point72 Asset Management, L.P.'s, at 7.7%. 11 filings are on record since July 17, 2025 (Schedule 13G/A, May 15, 2026).
Sell to companies like AngioDynamics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Point72 Asset Management, L.P. · Sole voting: 0 · Shared voting: 3,181,829 · Sole dispositive: 0 · Shared dispositive: 3,181,829 · SCHEDULE 13G/A, 2026-05-15
- · Reporting person: The Vanguard Group · Sole voting: 0 · Shared voting: 0 · Sole dispositive: 0 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-03-26
- · Reporting person: Divisadero Street Capital Management, LP · Sole voting: 0 · Shared voting: 4,576 · Sole dispositive: 0 · Shared dispositive: 4,576 · SCHEDULE 13G/A, 2026-02-13
- · Reporting person: Systematic Financial Management LP · Sole voting: 1,478,345 · Shared voting: 0 · Sole dispositive: 2,508,295 · Shared dispositive: 0 · SCHEDULE 13G, 2026-02-10
- · Holder: Kevin Kotler · Percent: 5.9% · SCHEDULE 13G
AngioDynamics, Inc. has 11 Schedule 13D or 13G filings on record since 2025-07-17. 3 holders' latest filing reports 5% or more of common stock, par value $0.01 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Point72 Asset Management, L.P. | 7.7% | 3,181,829 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| Systematic Financial Management LP | 6.1% | 2,508,295 | SCHEDULE 13G, 2026-02-10 | 2025-12-31 |
| 5.9% | 2,421,526 | SCHEDULE 13G, 2026-02-09 | 2026-01-06 | |
| Armistice Capital, LLC | 3.76% | 1,527,815 | SCHEDULE 13G/A, 2025-08-14 | 2025-06-30 |
| Millennium Management LLC | 2% | 842,548 | SCHEDULE 13G/A, 2026-01-08 | 2025-12-31 |
| Divisadero Street Capital Management, LP | 0.01% | 4,576 | SCHEDULE 13G/A, 2026-02-13 | 2025-12-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-26 | 2026-03-13 |
Holding shares or following this stake? See who's behind AngioDynamics, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on AngioDynamics, Inc. and the records around it.
AngioDynamics, Inc. elsewhere on the record
- Leadership changes Oct 2026
- Who owns it
Companies that share a holder
- SYSTEMATIC FINANCIAL MANAGEMENT LP also filed stake reports on 8 other companies: KVH INDUSTRIES INC \DE\ (Aug 2026), LSI INDUSTRIES INC (Aug 2026), MAGNACHIP SEMICONDUCTOR Corp (Feb 2026)
- Divisadero Street Capital Management, LP also filed stake reports on 22 other companies: Rush Street Interactive, Inc. (Sep 2026), Build-a-Bear Workshop, Inc (Aug 2026), Citi Trends, Inc. (Aug 2026)
- Integrated Core Strategies (US) LLC also filed stake reports on 63 other companies: SkinHealth Systems Inc. (Nov 2026), Infinite Eagle Acquisition Corp. (Nov 2026), Longeveron Inc. (Nov 2026)
Watch AngioDynamics, Inc.
Get an email when AngioDynamics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on AngioDynamics, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on AngioDynamics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on AngioDynamics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 0 | 3,181,829 | 0 | 3,181,829 | SCHEDULE 13G/A, 2026-05-15 |
| Point72 Capital Advisors, Inc. | 0 | 3,181,829 | 0 | 3,181,829 | SCHEDULE 13G/A, 2026-05-15 |
| Steven A. Cohen | 0 | 3,181,829 | 0 | 3,181,829 | SCHEDULE 13G/A, 2026-05-15 |
| Systematic Financial Management LP | 1,478,345 | 0 | 2,508,295 | 0 | SCHEDULE 13G, 2026-02-10 |
| Divisadero Street Capital Management, LP | 0 | 4,576 | 0 | 4,576 | SCHEDULE 13G/A, 2026-02-13 |
| William Zolezzi | 0 | 4,576 | 0 | 4,576 | SCHEDULE 13G/A, 2026-02-13 |
| Divisadero Street Partners, L.P. | 0 | 3,513 | 0 | 3,513 | SCHEDULE 13G/A, 2026-02-13 |
| Divisadero Street Partners GP, LLC | 0 | 3,513 | 0 | 3,513 | SCHEDULE 13G/A, 2026-02-13 |
| Divisadero Street Capital, LLC | 0 | 4,576 | 0 | 4,576 | SCHEDULE 13G/A, 2026-02-13 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-26 |
The latest filing identifies AngioDynamics, Inc. by CUSIP 03475V101 and gives its principal executive office as 14 Plaza Drive, Latham, NY 12110 (SCHEDULE 13G/A, 2026-05-15).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-17 | Point72 Asset Management, L.P. | 5.2% | SCHEDULE 13G |
| 2025-07-22 | Millennium Management LLC | 5.3% | SCHEDULE 13G |
| 2025-08-13 | Divisadero Street Capital Management, LP | 8.4% | SCHEDULE 13G/A |
| 2025-08-14 | Armistice Capital, LLC | 3.76% | SCHEDULE 13G/A |
| 2025-11-14 | Point72 Asset Management, L.P. | 6.2% | SCHEDULE 13G/A |
| 2026-01-08 | Millennium Management LLC | 2% | SCHEDULE 13G/A |
| 2026-02-09 | Kevin Kotler | 5.9% | SCHEDULE 13G |
| 2026-02-10 | Systematic Financial Management LP | 6.1% | SCHEDULE 13G |
| 2026-02-13 | Divisadero Street Capital Management, LP | 0.01% | SCHEDULE 13G/A |
| 2026-03-26 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-05-15 | Point72 Asset Management, L.P. | 7.7% | SCHEDULE 13G/A |
Questions about who owns AngioDynamics, Inc.
Who owns AngioDynamics, Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of AngioDynamics, Inc.: Point72 Asset Management, L.P. (7.7%, Schedule 13G/A, filed 2026-05-15), Systematic Financial Management LP (6.1%, Schedule 13G, filed 2026-02-10) and Kevin Kotler (5.9%, Schedule 13G, filed 2026-02-09).
Who are the largest shareholders of AngioDynamics, Inc.?
By the share each holder's latest filing reports, the largest holders of AngioDynamics, Inc. on this page are Point72 Asset Management, L.P. (7.7%), Systematic Financial Management LP (6.1%) and Kevin Kotler (5.9%).
When did Point72 Asset Management, L.P. buy into AngioDynamics, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Point72 Asset Management, L.P. on this page is the Schedule 13G, filed 2025-07-17, reporting 5.2%; its latest, Schedule 13G/A filed 2026-05-15, reports 7.7%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 11 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for AngioDynamics, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 8, 2026 | Leadership change: Eric Honroth appointed, President and Chief Executive Officer, and 1 more | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for AngioDynamics, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.